Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svane

Showing results (451-460 of 811) with videos related to

Pageof 82
Sort By:
British Journal of Cancer|May 26, 2025
Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumabInge Mansfield Noringriis, Marco Donia, Kasper Madsen, et al.
European Heart Journal|December 19, 1998
Social relations and extent and severity of coronary artery disease. The Stockholm Female Coronary Risk StudyK Orth-Gomér, M Horsten, S P Wamala, et al.
Journal of the American College of Cardiology|November 20, 1998
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)G Ruotolo, C G Ericsson, C Tettamanti, et al.
BMJ Oncology|June 13, 2025
Identification of protein biomarker candidates associated with organ-specific immune-related toxicity and response to management by plasma proteomicsAnders Handrup Kverneland, Ole Østergaard, Joel Emanuel Sohlin, et al.
Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.
Immuno-Oncology Technology|April 20, 2026
Fresh-blood immune profiling of immune-related adverse events in real-world patients identifies organ-specific and steroid responsiveness signaturesM Velasco Santiago, R S Jurlander, B Albieri, et al.
Frontiers in Endocrinology|March 14, 2019
Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis TreatmentSine Paasch Schiellerup, Kirsa Skov-Jeppesen, Johanne Agerlin Windeløv, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 17, 2017
Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypassKirstine N Bojsen-Møller, Carsten Dirksen, Maria S Svane, et al.
Oncoimmunology|December 25, 2012
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transferMarco Donia, Paolo Fagone, Ferdinando Nicoletti, et al.
American Journal of Obstetrics and Gynecology|April 23, 2002
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast densityEva Lundström, Alexander Christow, Wendy Kersemaekers, et al.
Pageof 82

Showing results (451-460 of 811) with videos related to

Sort By:
Pageof 82
British Journal of Cancer|May 26, 2025
Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumabInge Mansfield Noringriis, Marco Donia, Kasper Madsen, et al.
European Heart Journal|December 19, 1998
Social relations and extent and severity of coronary artery disease. The Stockholm Female Coronary Risk StudyK Orth-Gomér, M Horsten, S P Wamala, et al.
Journal of the American College of Cardiology|November 20, 1998
Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT)G Ruotolo, C G Ericsson, C Tettamanti, et al.
BMJ Oncology|June 13, 2025
Identification of protein biomarker candidates associated with organ-specific immune-related toxicity and response to management by plasma proteomicsAnders Handrup Kverneland, Ole Østergaard, Joel Emanuel Sohlin, et al.
Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.
Immuno-Oncology Technology|April 20, 2026
Fresh-blood immune profiling of immune-related adverse events in real-world patients identifies organ-specific and steroid responsiveness signaturesM Velasco Santiago, R S Jurlander, B Albieri, et al.
Frontiers in Endocrinology|March 14, 2019
Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis TreatmentSine Paasch Schiellerup, Kirsa Skov-Jeppesen, Johanne Agerlin Windeløv, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 17, 2017
Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypassKirstine N Bojsen-Møller, Carsten Dirksen, Maria S Svane, et al.
Oncoimmunology|December 25, 2012
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transferMarco Donia, Paolo Fagone, Ferdinando Nicoletti, et al.
American Journal of Obstetrics and Gynecology|April 23, 2002
Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast densityEva Lundström, Alexander Christow, Wendy Kersemaekers, et al.
Pageof 82